
Rasem Mourad
Examiner (ID: 7274, Phone: (571)270-7770 , Office: P/2836 )
| Most Active Art Unit | 2836 |
| Art Unit(s) | 2836 |
| Total Applications | 617 |
| Issued Applications | 444 |
| Pending Applications | 46 |
| Abandoned Applications | 142 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5284906
[patent_doc_number] => 20090098581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'Tyrosine phosphorylation sites'
[patent_app_type] => utility
[patent_app_number] => 12/148547
[patent_app_country] => US
[patent_app_date] => 2008-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 36484
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20090098581.pdf
[firstpage_image] =>[orig_patent_app_number] => 12148547
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/148547 | Tyrosine phosphorylation sites | Apr 17, 2008 | Issued |
Array
(
[id] => 5336751
[patent_doc_number] => 20090053215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of CD63'
[patent_app_type] => utility
[patent_app_number] => 12/102983
[patent_app_country] => US
[patent_app_date] => 2008-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 19244
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053215.pdf
[firstpage_image] =>[orig_patent_app_number] => 12102983
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/102983 | Cytotoxicity mediation of cells evidencing surface expression of CD63 | Apr 14, 2008 | Abandoned |
Array
(
[id] => 4886303
[patent_doc_number] => 20080260635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of MCSP'
[patent_app_type] => utility
[patent_app_number] => 12/102953
[patent_app_country] => US
[patent_app_date] => 2008-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15736
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20080260635.pdf
[firstpage_image] =>[orig_patent_app_number] => 12102953
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/102953 | Cytotoxicity mediation of cells evidencing surface expression of MCSP | Apr 14, 2008 | Abandoned |
Array
(
[id] => 5409541
[patent_doc_number] => 20090123439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'DIAGNOSTIC AND PROGNOSIS METHODS FOR CANCER STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/102558
[patent_app_country] => US
[patent_app_date] => 2008-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 46261
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20090123439.pdf
[firstpage_image] =>[orig_patent_app_number] => 12102558
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/102558 | DIAGNOSTIC AND PROGNOSIS METHODS FOR CANCER STEM CELLS | Apr 13, 2008 | Abandoned |
Array
(
[id] => 4675542
[patent_doc_number] => 20080213171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Cancerous disease modifying antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/102662
[patent_app_country] => US
[patent_app_date] => 2008-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5033
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213171.pdf
[firstpage_image] =>[orig_patent_app_number] => 12102662
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/102662 | Cancerous disease modifying antibodies | Apr 13, 2008 | Abandoned |
Array
(
[id] => 6453282
[patent_doc_number] => 20100105571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'Protein Signature/Markers for the Detection of Adenocarcinoma'
[patent_app_type] => utility
[patent_app_number] => 12/593448
[patent_app_country] => US
[patent_app_date] => 2008-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10253
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20100105571.pdf
[firstpage_image] =>[orig_patent_app_number] => 12593448
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/593448 | Protein Signature/Markers for the Detection of Adenocarcinoma | Mar 24, 2008 | Abandoned |
Array
(
[id] => 6313801
[patent_doc_number] => 20100111874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'METHOD OF CANCER DETECTION AND TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 12/532375
[patent_app_country] => US
[patent_app_date] => 2008-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7876
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20100111874.pdf
[firstpage_image] =>[orig_patent_app_number] => 12532375
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/532375 | METHOD OF CANCER DETECTION AND TREATMENT | Mar 16, 2008 | Abandoned |
Array
(
[id] => 5508452
[patent_doc_number] => 20090081659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Reagents for the detection of protein phosphorylation in carcinoma signaling pathways'
[patent_app_type] => utility
[patent_app_number] => 12/075065
[patent_app_country] => US
[patent_app_date] => 2008-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 33369
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081659.pdf
[firstpage_image] =>[orig_patent_app_number] => 12075065
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/075065 | Reagents for the detection of protein phosphorylation in carcinoma signaling pathways | Mar 6, 2008 | Abandoned |
Array
(
[id] => 6631870
[patent_doc_number] => 20100173322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways'
[patent_app_type] => utility
[patent_app_number] => 12/074876
[patent_app_country] => US
[patent_app_date] => 2008-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 20537
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 45
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173322.pdf
[firstpage_image] =>[orig_patent_app_number] => 12074876
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/074876 | Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways | Mar 5, 2008 | Abandoned |
Array
(
[id] => 6441715
[patent_doc_number] => 20100104586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'Treatment of Carcinomas with a Combination of EGF-Pathway and Telomerase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/530014
[patent_app_country] => US
[patent_app_date] => 2008-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11454
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20100104586.pdf
[firstpage_image] =>[orig_patent_app_number] => 12530014
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/530014 | Treatment of carcinomas with a combination of EGF-pathway and telomerase inhibitors | Mar 5, 2008 | Issued |
Array
(
[id] => 4887486
[patent_doc_number] => 20080261818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Methods of Identifying Pancreatic Cancer Cells'
[patent_app_type] => utility
[patent_app_number] => 12/041350
[patent_app_country] => US
[patent_app_date] => 2008-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10006
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20080261818.pdf
[firstpage_image] =>[orig_patent_app_number] => 12041350
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/041350 | Methods of identifying pancreatic cancer cells | Mar 2, 2008 | Issued |
Array
(
[id] => 4698852
[patent_doc_number] => 20080221036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'Use of AGT and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 12/071757
[patent_app_country] => US
[patent_app_date] => 2008-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6504
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20080221036.pdf
[firstpage_image] =>[orig_patent_app_number] => 12071757
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/071757 | Use of AGT and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions | Feb 25, 2008 | Abandoned |
Array
(
[id] => 4823023
[patent_doc_number] => 20080227708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Methods Of Attenuating Prostate Tumor Growth By Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3)'
[patent_app_type] => utility
[patent_app_number] => 12/036822
[patent_app_country] => US
[patent_app_date] => 2008-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5151
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227708.pdf
[firstpage_image] =>[orig_patent_app_number] => 12036822
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/036822 | Methods Of Attenuating Prostate Tumor Growth By Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) | Feb 24, 2008 | Abandoned |
Array
(
[id] => 4872738
[patent_doc_number] => 20080199472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'Use of a polypeptide domain to modulate the tumorigenic and metastatic potential of cancer cells'
[patent_app_type] => utility
[patent_app_number] => 12/070239
[patent_app_country] => US
[patent_app_date] => 2008-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4655
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20080199472.pdf
[firstpage_image] =>[orig_patent_app_number] => 12070239
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/070239 | Use of a polypeptide domain to modulate the tumorigenic and metastatic potential of cancer cells | Feb 13, 2008 | Abandoned |
Array
(
[id] => 6395496
[patent_doc_number] => 20100178299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-15
[patent_title] => 'METHODS AND COMPOSITIONS FOR IMPROVING IMMUNE RESPONSES'
[patent_app_type] => utility
[patent_app_number] => 12/527181
[patent_app_country] => US
[patent_app_date] => 2008-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 33966
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20100178299.pdf
[firstpage_image] =>[orig_patent_app_number] => 12527181
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/527181 | METHODS AND COMPOSITIONS FOR IMPROVING IMMUNE RESPONSES | Feb 12, 2008 | Abandoned |
Array
(
[id] => 4873653
[patent_doc_number] => 20080200387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'ANTI-ANGIOGENIC PROTEIN, COMPOSITION AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/030847
[patent_app_country] => US
[patent_app_date] => 2008-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8168
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0200/20080200387.pdf
[firstpage_image] =>[orig_patent_app_number] => 12030847
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/030847 | ANTI-ANGIOGENIC PROTEIN, COMPOSITION AND USE THEREOF | Feb 12, 2008 | Abandoned |
Array
(
[id] => 6322974
[patent_doc_number] => 20100113747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'Coupling of Antibody Polypeptides at the C-Terminus'
[patent_app_type] => utility
[patent_app_number] => 12/528905
[patent_app_country] => US
[patent_app_date] => 2008-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15929
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20100113747.pdf
[firstpage_image] =>[orig_patent_app_number] => 12528905
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/528905 | Coupling of Antibody Polypeptides at the C-Terminus | Feb 7, 2008 | Abandoned |
Array
(
[id] => 4711682
[patent_doc_number] => 20080300208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'Isociatrate dehydrogenase and uses therof'
[patent_app_type] => utility
[patent_app_number] => 12/069188
[patent_app_country] => US
[patent_app_date] => 2008-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 17425
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20080300208.pdf
[firstpage_image] =>[orig_patent_app_number] => 12069188
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/069188 | Isociatrate dehydrogenase and uses therof | Feb 6, 2008 | Abandoned |
Array
(
[id] => 4859105
[patent_doc_number] => 20080267955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'FRIZZLED 9 AS TUMOR MARKER'
[patent_app_type] => utility
[patent_app_number] => 12/019608
[patent_app_country] => US
[patent_app_date] => 2008-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 10179
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20080267955.pdf
[firstpage_image] =>[orig_patent_app_number] => 12019608
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/019608 | FRIZZLED 9 AS TUMOR MARKER | Jan 23, 2008 | Abandoned |
Array
(
[id] => 4726591
[patent_doc_number] => 20080206132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Cancerous Disease Modifying Antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/017827
[patent_app_country] => US
[patent_app_date] => 2008-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17364
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20080206132.pdf
[firstpage_image] =>[orig_patent_app_number] => 12017827
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/017827 | Cancerous disease modifying antibodies | Jan 21, 2008 | Issued |